[Form 4] Smurfit Westrock plc Insider Trading Activity
Insider transaction by Smurfit Westrock plc (SW): The company's Chief Accounting Officer, Irene Page, acquired 30 ordinary shares and 292 restricted stock units (RSUs) on 09/18/2025 at no cost, arising from dividend-equivalent accruals tied to existing awards. After the transactions, Ms. Page beneficially owned 49,397 ordinary shares in total and held 30,354 RSUs that vest and settle into ordinary shares: 16,623 RSUs in February 2026 and 13,731 RSUs in February 2027. The filing was signed by an attorney-in-fact on behalf of the reporting person.
- Dividend-equivalent accruals were credited to RSUs, aligning executive compensation with shareholder distributions
- Clear vesting schedule disclosed: 16,623 RSUs vest in February 2026 and 13,731 RSUs vest in February 2027, providing transparency on future potential dilution and insider holdings
- Reporting compliance demonstrated by Form 4 filing and inclusion of Exhibit 24.1 Power of Attorney
- None.
Insights
TL;DR: Routine dividend-equivalent accruals increased an officer's share and RSU holdings; transaction appears non-material to valuation.
The Form 4 documents non-cash acquisitions by the Chief Accounting Officer resulting from dividend equivalents credited to outstanding restricted stock unit awards and scheduled vesting of existing RSUs. The 30 ordinary shares and 292 RSUs were recorded at $0 consistent with grant/dividend-credit mechanics rather than open-market purchases. Aggregate beneficial ownership totals (49,397 shares and 30,354 RSUs) reflect ongoing compensation settlement schedules with near-term vesting of a material portion in February 2026. For investors, this is a governance and compensation disclosure rather than an operational or financial performance signal.
TL;DR: Disclosure shows standard executive compensation mechanics; timing and vesting schedule are clearly reported.
The filing transparently reports the mechanics of dividend-equivalent accruals and the vesting timetable for RSUs, which is important for assessing potential insider-aligned incentives and dilution timing. The attorney-in-fact signature is noted, and exhibits include a power of attorney. There are no indications of unusual trading, option exercises, or departures from standard award terms in this filing.